| Dr Adam Patrick Mccormick, DDS | |
|
2297 N Hill Field Rd Ste 105, Layton, UT 84041-6928 | |
| (801) 779-0506 | |
| (801) 779-4344 |
| Full Name | Dr Adam Patrick Mccormick |
|---|---|
| Gender | Male |
| Speciality | Dentist - Oral And Maxillofacial Surgery |
| Location | 2297 N Hill Field Rd Ste 105, Layton, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144456542 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | 0442000072 (Virginia) | Secondary |
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | 8018830-9924 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Patrick Mccormick, DDS 2297 N Hill Field Rd Ste 105, Layton, UT 84041-6928 Ph: (801) 779-0506 | Dr Adam Patrick Mccormick, DDS 2297 N Hill Field Rd Ste 105, Layton, UT 84041-6928 Ph: (801) 779-0506 |
News Archive
Today marks the start of the first-ever World Hepatitis Summit hosted in Glasgow, Scotland, at the Scottish Exhibition and Conference Centre.
Bronchiectasis is independently associated with mortality risk among patients with moderate-to-severe chronic obstructive pulmonary disease, Spanish research shows.
Gamma Pharmaceuticals Inc. (the "Company") announced it has successfully completed the registration of six of the Company's Brand Trademarks with The State Trademark Bureau of China.
The sex hormone estrogen tempers the killing activity of a specific group of immune cells, the cytotoxic T cells (CTLs), which are known to attack tumor cells and cells infected by viruses. The key player in this process is a cytotoxic T cell molecule which has been known for a long time and which scientists have named EBAG9.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
› Verified 2 days ago
Dr. Brad J Dawson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1597 Woodland Park Dr Ste 200, Layton, UT 84041 Phone: 801-544-1940 Fax: 801-896-0645 | |
Darin Hartvigsen, Dentist Medicare: Medicare Enrolled Practice Location: 1492 W Antelope Dr, Layton, UT 84041 Phone: 801-776-6566 | |
Dr. Andrew Rasmussen Mcfarland, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1482 N 160 W, Layton, UT 84041 Phone: 954-599-2931 | |
Dr. Dayana Arreola, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 836 S Angel St Ste 100, Layton, UT 84041 Phone: 801-544-9777 | |
Dennis Dedecker, DDS, PC Dentist Medicare: Medicare Enrolled Practice Location: 2185 N 1700 W, #204, Layton, UT 84041 Phone: 801-773-9790 Fax: 801-773-9792 | |
Dr. Taylor James Metcalf, D.M.D, M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 984 N 3200 W, Layton, UT 84041 Phone: 801-547-8800 | |
Glenn A. Zeh, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1147 Rosewood Ln, Ste 1, Layton, UT 84041 Phone: 801-544-2256 |